Show simple item record

dc.contributor.authorPérez-Castro, Miguel Ángel
dc.contributor.authorEraña, Hasier
dc.contributor.authorVidal, Enric
dc.contributor.authorCharco, Jorge M.
dc.contributor.authorLorenzo, Nuria L.
dc.contributor.authorGonçalves-Anjo, Nuno
dc.contributor.authorGalarza-Ahumada, Josu
dc.contributor.authorDíaz-Domínguez, Carlos M.
dc.contributor.authorPiñeiro, Patricia
dc.contributor.authorGonzález-Miranda, Ezequiel
dc.contributor.authorGiler, Samanta
dc.contributor.authorTelling, Glenn
dc.contributor.authorSánchez-Martín, Manuel A.
dc.contributor.authorGarrido, Joseba
dc.contributor.authorGeijo, Mariví
dc.contributor.authorRequena, Jesús R.
dc.contributor.authorCastilla, Joaquín
dc.contributor.otherProducció Animalca
dc.date.accessioned2025-03-12T09:10:38Z
dc.date.available2025-03-12T09:10:38Z
dc.date.issued2025-01-22
dc.identifier.citationPérez-Castro, Miguel A., Hasier Eraña, Enric Vidal, Jorge M. Charco, Nuria L. Lorenzo, Nuno Gonçalves-Anjo, Josu Galarza-Ahumada, et al. 2025. “Cofactors Facilitate Bona Fide Prion Misfolding in Vitro but Are Not Necessary for the Infectivity of Recombinant Murine Prions.” PLoS Pathogens 21 (1): e1012890. https://doi.org/10.1371/journal.ppat.1012890.ca
dc.identifier.issn1553-7366ca
dc.identifier.urihttp://hdl.handle.net/20.500.12327/3726
dc.description.abstractPrion diseases, particularly sporadic cases, pose a challenge due to their complex nature and heterogeneity. The underlying mechanism of the spontaneous conversion from PrPC to PrPSc, the hallmark of prion diseases, remains elusive. To shed light on this process and the involvement of cofactors, we have developed an in vitro system that faithfully mimics spontaneous prion misfolding using minimal components. By employing this PMSA methodology and introducing an isoleucine residue at position 108 in mouse PrP, we successfully generated recombinant murine prion strains with distinct biochemical and biological properties. Our study aimed to explore the influence of a polyanionic cofactor in modulating strain selection and infectivity in de novo-generated synthetic prions. These results not only validate PMSA as a robust method for generating diverse bona fide recombinant prions but also emphasize the significance of cofactors in shaping specific prion conformers capable of crossing species barriers. Interestingly, once these conformers are established, our findings suggest that cofactors are not necessary for their infectivity. This research provides valuable insights into the propagation and maintenance of the pathobiological features of cross-species transmissible recombinant murine prion and highlights the intricate interplay between cofactors and prion strain characteristics.ca
dc.description.sponsorshipThe present work was partially funded by three different grants awarded by “Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación” (Spanish Government), grant numbers PID2021-122201OB-C21 granted to J.C., PID2021-1222010B-C22 granted to E.V., and PID2020-117465GB-I00 granted to J.R.R., funded by MCIN/ AEI /10.13039/501100011033 and co-financed by the European Regional Development Fund (ERDF). EFA031/01 NEURO-COOP, which is co-funded at 65% by the European Union through Programa Interreg VI-A España-Francia-Andorra (POCTEFA 2021-2027) granted to J.C. and H.E. Additional funding was provided by the Instituto de Salud Carlos III (ISCIII), grant number AC21_2/00024, granted to J.C. Additionally, CIC bioGUNE currently holds a Severo Ochoa Excellence accreditation, CEX2021-001136-S granted to J.C., also funded by Ministerio de Ciencia e Innovación/AEI /10.13039/501100011033. Transgenic Facility, directed by M.A.S.-M., is supported by Instituto de Salud Carlos III (ISCIII), co-funded by the European Union grant PT23/00123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.ca
dc.format.extent49ca
dc.language.isoengca
dc.publisherPublic Library of Scienceca
dc.relation.ispartofPLoS Pathogensca
dc.rightsAttribution 4.0 Internationalca
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleCofactors facilitate bona fide prion misfolding in vitro but are not necessary for the infectivity of recombinant murine prionsca
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.relation.projectIDMICINN/Programa Estatal para impulsar la investigación científico-técnica y su transferencia/PID2021-122201OB-C21/ES/ANALISIS DEL MALPLEGAMIENTO IN VITRO DE UNA DIVERSIDAD DE PROTEINAS DEL PRION PARA LA GENERACION DE NUEVAS ENTIDADES INFECCIOSAS Y DESARROLLO DE APROXIMACIONES TERAPEUTICAS/ca
dc.relation.projectIDMICINN/Programa Estatal para impulsar la investigación científico-técnica y su transferencia/PID2021-122201OB-C22/ES/DESARROLLO DE INNOVADORES MODELOS DE ENFERMEDADES PRIONICAS Y ESTUDIO DE LA PATOBIOLOGIA DE PRIONES SINTETICOS EN RATONES TRANSGENICOS Y HOSPEDADORES POCO COMUNES/ca
dc.relation.projectIDMC/Programa Estatal de generación del conocimiento y fortalecimiento científico y tecnológico del sistema I+D+I y Programa Estatal de I+D+I orientada a los retos de la sociedad/PID2020-117465GB-I00/ES/ /ca
dc.relation.projectIDISCIII/ /AC21_2-00024/ES/Biomarcadores prodrómicos en Insomnio Familiar Letal: Un estudio longitudinal en humanos y ratones/ca
dc.relation.projectIDMICINN/Programa Estatal de generación del conocimiento y fortalecimiento científico y tecnológico del sistema I+D+I/CEX2021-001136-S/ES/ /ca
dc.relation.projectIDISCIII/ /PT23-00123/ES/ /ca
dc.relation.projectIDFEDER/ / /EU/ /ca
dc.relation.projectIDEC/INTERREG-POCTEFA/EFA031-01/EU/ /NEURO-COOPca
dc.subject.udc619ca
dc.identifier.doihttps://doi.org/10.1371/journal.ppat.1012890ca
dc.contributor.groupSanitat Animalca


Files in this item

 

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Share on TwitterShare on LinkedinShare on FacebookShare on TelegramShare on WhatsappPrint